Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
Dianthus Therapeutics granted inducement awards to six newly hired non-executive employees as approved by its independent Compensation Committee. The awards consist of options to purchase an aggregate of 87,000 shares at an exercise price of $106.02 per share with a 10-year term.
Key figures
- Exercise price
- 106.02
- Shares granted
- 87000
- Option term years
- 10
- Initial vest percent
- 25
- Subsequent vest months
- 36
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.